2019

Precision IBD acquires Prometheus Labs to form Prometheus Biosciences

2019

Precision IBD nominates first clinical candidate mAb, PR200

1996

Prometheus Labs launches 1st diagnostic, pANCA

1992

1st sample collected. The beginning of our GI Medicines Platform